New Genetic Biomarkers Predicting Azathioprine Blood Concentrations in Combination Therapy with 5-Aminosalicylic Acid

BACKGROUND AND AIMS: Azathioprine (AZA) is widely used for the treatment of inflammatory bowel disease (IBD) patients. AZA is catabolized by thiopurine S-methyltransferase (TPMT), which exhibits genetic polymorphisms. It has also been reported that 5-aminosalicylic acid (5-ASA) inhibits TPMT activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchiyama, Kazuhiko, Takagi, Tomohisa, Iwamoto, Yasunori, Kondo, Norihiko, Okayama, Tetsuya, Yoshida, Naohisa, Kamada, Kazuhiro, Katada, Kazuhiro, Handa, Osamu, Ishikawa, Takeshi, Yasuda, Hiroaki, Sakagami, Junichi, Konishi, Hideyuki, Yagi, Nobuaki, Naito, Yuji, Itoh, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999094/
https://www.ncbi.nlm.nih.gov/pubmed/24762746
http://dx.doi.org/10.1371/journal.pone.0095080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999094/
https://www.ncbi.nlm.nih.gov/pubmed/24762746
http://dx.doi.org/10.1371/journal.pone.0095080

Ejemplares similares